The latest closing stock price for TScan Therapeutics as of May 30, 2025 is 1.43.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-864 today, roughly -1 times their original investment - a -39.25% compound annual growth rate over 4 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.29, which is 549.7% above the current share price.
The TScan Therapeutics 52-week low stock price is 1.02, which is 28.7% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 4.04.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-864 today, roughly -1 times their original investment - a -39.25% compound annual growth rate over 4 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.29, which is 549.7% above the current share price.
The TScan Therapeutics 52-week low stock price is 1.02, which is 28.7% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 4.04.